aluates Reports

$ 0.0

Automative

Global Esophageal Disorders Treatment Market Research Report 2025

Published Date: January 2025

Report Code: QYRE-Auto-0Y11193

Global Esophageal Disorders Treatment Market Research Report 2022

BUY CHAPTERS

Global Esophageal Disorders Treatment Market Research Report 2025

Code: QYRE-Auto-0Y11193

Report

January 2025

Pages:73

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer Inc

Bristol Myers Squibb Company

Perrigo Company plc

Astrazeneca plc

GlaxoSmithKline PLC

Johnson & Johnson

Teva Pharmaceuticals

Medtronic Inc

Torax Medical

Esophageal Disorders Treatment Market Size

The global market for Esophageal Disorders Treatment was valued at US$ 1280 million in the year 2024 and is projected to reach a revised size of US$ 1901 million by 2031, growing at a CAGR of 5.9% during the forecast period.

Esophageal Disorders Treatment Market

Infectious Esophageal Disorders are the infection caused by the bacteria, fungi or virus in the esophagus. The common symptoms of infectious esophageal disorders are fever, heartburn, difficulty swallowing, swollen glands, painful swallowing.The treatment of esophageal disorders aims to alleviate symptoms, prevent complications, and improve the quality of life for patients. The specific treatment approach depends on the type and severity of the disorder. The treatment options can range from lifestyle modifications, medication therapy, minimally invasive procedures, to surgical interventions.

The global esophageal disorders treatment market refers to the market for therapies and treatments used to manage and treat various disorders affecting the esophagus. Esophageal disorders include conditions such as gastroesophageal reflux disease (GERD), esophagitis, esophageal cancer, Barrett’s esophagus, achalasia, and other motility disorders.

The global esophageal disorders treatment market is driven by several factors, including the increasing prevalence of esophageal disorders, changing dietary habits, rising prevalence of risk factors such as obesity and smoking, advancements in diagnostic techniques, and the need for effective management strategies. Additionally, the development of innovative therapies and ongoing research studies contribute to the market’s growth.

Geographically, North America holds a significant share in the global esophageal disorders treatment market, driven by the high prevalence of esophageal disorders and well-established healthcare infrastructure. Europe also has a considerable market presence, fueled by increasing awareness and adoption of advanced treatment options. Additionally, the Asia Pacific region is expected to witness significant growth due to the rising prevalence of risk factors associated with esophageal disorders and improving healthcare facilities.

Key players in the global esophageal disorders treatment market include pharmaceutical companies, medical device manufacturers, and healthcare providers. These companies focus on developing new treatment options, conducting clinical trials, and providing effective therapies to improve patient outcomes and quality of life. Some notable players in the market include AstraZeneca, Takeda Pharmaceutical Company Limited, Medtronic, Boston Scientific Corporation, and Olympus Corporation.

In summary, the global esophageal disorders treatment market is driven by factors such as the increasing prevalence of esophageal disorders, advancements in treatment options, and the need for effective management strategies. The market is expected to witness significant growth as research and development efforts continue to improve understanding of these disorders and lead to the development of innovative therapies. With ongoing innovations in treatment approaches and increasing investments in research, the esophageal disorders treatment market presents opportunities for manufacturers and healthcare providers to improve patient outcomes and quality of life.

This report aims to provide a comprehensive presentation of the global market for Esophageal Disorders Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Esophageal Disorders Treatment.

The Esophageal Disorders Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Esophageal Disorders Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Esophageal Disorders Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Esophageal Disorders Treatment Market Report

Report Metric	Details
Report Name	Esophageal Disorders Treatment Market
Accounted market size in year	US$ 1280 million
Forecasted market size in 2031	US$ 1901 million
CAGR	5.9%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Antacids H2 Blockers Proton Pump Inhibitors Others
Segment by Application	Hospital Pharmacies Retail Pharmacy Online Pharmacy Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Bristol-Myers Squibb Company, Perrigo Company Plc, AstraZeneca Plc, GlaxoSmithKline Plc, Johnson & Johnson, Teva Pharmaceuticals, Medtronic Plc, Torax Medical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Esophageal Disorders Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Esophageal Disorders Treatment Market growing?

Ans: The Esophageal Disorders Treatment Market witnessing a CAGR of 5.9% during the forecast period 2025-2031.

What is the Esophageal Disorders Treatment Market size in 2031?

Ans: The Esophageal Disorders Treatment Market size in 2031 will be US$ 1901 million.

Who are the main players in the Esophageal Disorders Treatment Market report?

Ans: The main players in the Esophageal Disorders Treatment Market are Pfizer, Bristol-Myers Squibb Company, Perrigo Company Plc, AstraZeneca Plc, GlaxoSmithKline Plc, Johnson & Johnson, Teva Pharmaceuticals, Medtronic Plc, Torax Medical

What are the Application segmentation covered in the Esophageal Disorders Treatment Market report?

Ans: The Applications covered in the Esophageal Disorders Treatment Market report are Hospital Pharmacies, Retail Pharmacy, Online Pharmacy, Others

What are the Type segmentation covered in the Esophageal Disorders Treatment Market report?

Ans: The Types covered in the Esophageal Disorders Treatment Market report are Antacids, H2 Blockers, Proton Pump Inhibitors, Others

Recommended Reports

Esophageal Devices & Stents

Gastrointestinal Disorders

Esophageal & Swallowing Disorders

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Esophageal Disorders Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Antacids

1.2.3 H2 Blockers

1.2.4 Proton Pump Inhibitors

1.2.5 Others

1.3 Market by Application

1.3.1 Global Esophageal Disorders Treatment Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacy

1.3.4 Online Pharmacy

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Esophageal Disorders Treatment Market Perspective (2020-2031)

2.2 Global Esophageal Disorders Treatment Growth Trends by Region

2.2.1 Global Esophageal Disorders Treatment Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Esophageal Disorders Treatment Historic Market Size by Region (2020-2025)

2.2.3 Esophageal Disorders Treatment Forecasted Market Size by Region (2026-2031)

2.3 Esophageal Disorders Treatment Market Dynamics

2.3.1 Esophageal Disorders Treatment Industry Trends

2.3.2 Esophageal Disorders Treatment Market Drivers

2.3.3 Esophageal Disorders Treatment Market Challenges

2.3.4 Esophageal Disorders Treatment Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Esophageal Disorders Treatment Players by Revenue

3.1.1 Global Top Esophageal Disorders Treatment Players by Revenue (2020-2025)

3.1.2 Global Esophageal Disorders Treatment Revenue Market Share by Players (2020-2025)

3.2 Global Esophageal Disorders Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Esophageal Disorders Treatment Revenue

3.4 Global Esophageal Disorders Treatment Market Concentration Ratio

3.4.1 Global Esophageal Disorders Treatment Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Esophageal Disorders Treatment Revenue in 2024

3.5 Global Key Players of Esophageal Disorders Treatment Head office and Area Served

3.6 Global Key Players of Esophageal Disorders Treatment, Product and Application

3.7 Global Key Players of Esophageal Disorders Treatment, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Esophageal Disorders Treatment Breakdown Data by Type

4.1 Global Esophageal Disorders Treatment Historic Market Size by Type (2020-2025)

4.2 Global Esophageal Disorders Treatment Forecasted Market Size by Type (2026-2031)

5 Esophageal Disorders Treatment Breakdown Data by Application

5.1 Global Esophageal Disorders Treatment Historic Market Size by Application (2020-2025)

5.2 Global Esophageal Disorders Treatment Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Esophageal Disorders Treatment Market Size (2020-2031)

6.2 North America Esophageal Disorders Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Esophageal Disorders Treatment Market Size by Country (2020-2025)

6.4 North America Esophageal Disorders Treatment Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Esophageal Disorders Treatment Market Size (2020-2031)

7.2 Europe Esophageal Disorders Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Esophageal Disorders Treatment Market Size by Country (2020-2025)

7.4 Europe Esophageal Disorders Treatment Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Esophageal Disorders Treatment Market Size (2020-2031)

8.2 Asia-Pacific Esophageal Disorders Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Esophageal Disorders Treatment Market Size by Region (2020-2025)

8.4 Asia-Pacific Esophageal Disorders Treatment Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Esophageal Disorders Treatment Market Size (2020-2031)

9.2 Latin America Esophageal Disorders Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Esophageal Disorders Treatment Market Size by Country (2020-2025)

9.4 Latin America Esophageal Disorders Treatment Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Esophageal Disorders Treatment Market Size (2020-2031)

10.2 Middle East & Africa Esophageal Disorders Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Esophageal Disorders Treatment Market Size by Country (2020-2025)

10.4 Middle East & Africa Esophageal Disorders Treatment Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Esophageal Disorders Treatment Introduction

11.1.4 Pfizer Revenue in Esophageal Disorders Treatment Business (2020-2025)

11.1.5 Pfizer Recent Development

11.2 Bristol-Myers Squibb Company

11.2.1 Bristol-Myers Squibb Company Company Details

11.2.2 Bristol-Myers Squibb Company Business Overview

11.2.3 Bristol-Myers Squibb Company Esophageal Disorders Treatment Introduction

11.2.4 Bristol-Myers Squibb Company Revenue in Esophageal Disorders Treatment Business (2020-2025)

11.2.5 Bristol-Myers Squibb Company Recent Development

11.3 Perrigo Company Plc

11.3.1 Perrigo Company Plc Company Details

11.3.2 Perrigo Company Plc Business Overview

11.3.3 Perrigo Company Plc Esophageal Disorders Treatment Introduction

11.3.4 Perrigo Company Plc Revenue in Esophageal Disorders Treatment Business (2020-2025)

11.3.5 Perrigo Company Plc Recent Development

11.4 AstraZeneca Plc

11.4.1 AstraZeneca Plc Company Details

11.4.2 AstraZeneca Plc Business Overview

11.4.3 AstraZeneca Plc Esophageal Disorders Treatment Introduction

11.4.4 AstraZeneca Plc Revenue in Esophageal Disorders Treatment Business (2020-2025)

11.4.5 AstraZeneca Plc Recent Development

11.5 GlaxoSmithKline Plc

11.5.1 GlaxoSmithKline Plc Company Details

11.5.2 GlaxoSmithKline Plc Business Overview

11.5.3 GlaxoSmithKline Plc Esophageal Disorders Treatment Introduction

11.5.4 GlaxoSmithKline Plc Revenue in Esophageal Disorders Treatment Business (2020-2025)

11.5.5 GlaxoSmithKline Plc Recent Development

11.6 Johnson & Johnson

11.6.1 Johnson & Johnson Company Details

11.6.2 Johnson & Johnson Business Overview

11.6.3 Johnson & Johnson Esophageal Disorders Treatment Introduction

11.6.4 Johnson & Johnson Revenue in Esophageal Disorders Treatment Business (2020-2025)

11.6.5 Johnson & Johnson Recent Development

11.7 Teva Pharmaceuticals

11.7.1 Teva Pharmaceuticals Company Details

11.7.2 Teva Pharmaceuticals Business Overview

11.7.3 Teva Pharmaceuticals Esophageal Disorders Treatment Introduction

11.7.4 Teva Pharmaceuticals Revenue in Esophageal Disorders Treatment Business (2020-2025)

11.7.5 Teva Pharmaceuticals Recent Development

11.8 Medtronic Plc

11.8.1 Medtronic Plc Company Details

11.8.2 Medtronic Plc Business Overview

11.8.3 Medtronic Plc Esophageal Disorders Treatment Introduction

11.8.4 Medtronic Plc Revenue in Esophageal Disorders Treatment Business (2020-2025)

11.8.5 Medtronic Plc Recent Development

11.9 Torax Medical

11.9.1 Torax Medical Company Details

11.9.2 Torax Medical Business Overview

11.9.3 Torax Medical Esophageal Disorders Treatment Introduction

11.9.4 Torax Medical Revenue in Esophageal Disorders Treatment Business (2020-2025)

11.9.5 Torax Medical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Pfizer Inc

Bristol Myers Squibb Company

Perrigo Company plc

Astrazeneca plc

GlaxoSmithKline PLC

Johnson & Johnson

Teva Pharmaceuticals

Medtronic Inc

Torax Medical

List of Tables

Table 1. Global Esophageal Disorders Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Antacids

Table 3. Key Players of H2 Blockers

Table 4. Key Players of Proton Pump Inhibitors

Table 5. Key Players of Others

Table 6. Global Esophageal Disorders Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Esophageal Disorders Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Esophageal Disorders Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Esophageal Disorders Treatment Market Share by Region (2020-2025)

Table 10. Global Esophageal Disorders Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Esophageal Disorders Treatment Market Share by Region (2026-2031)

Table 12. Esophageal Disorders Treatment Market Trends

Table 13. Esophageal Disorders Treatment Market Drivers

Table 14. Esophageal Disorders Treatment Market Challenges

Table 15. Esophageal Disorders Treatment Market Restraints

Table 16. Global Esophageal Disorders Treatment Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Esophageal Disorders Treatment Market Share by Players (2020-2025)

Table 18. Global Top Esophageal Disorders Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Esophageal Disorders Treatment as of 2024)

Table 19. Ranking of Global Top Esophageal Disorders Treatment Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Esophageal Disorders Treatment Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Esophageal Disorders Treatment, Headquarters and Area Served

Table 22. Global Key Players of Esophageal Disorders Treatment, Product and Application

Table 23. Global Key Players of Esophageal Disorders Treatment, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Esophageal Disorders Treatment Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Esophageal Disorders Treatment Revenue Market Share by Type (2020-2025)

Table 27. Global Esophageal Disorders Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Esophageal Disorders Treatment Revenue Market Share by Type (2026-2031)

Table 29. Global Esophageal Disorders Treatment Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Esophageal Disorders Treatment Revenue Market Share by Application (2020-2025)

Table 31. Global Esophageal Disorders Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Esophageal Disorders Treatment Revenue Market Share by Application (2026-2031)

Table 33. North America Esophageal Disorders Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Esophageal Disorders Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Esophageal Disorders Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Esophageal Disorders Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Esophageal Disorders Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Esophageal Disorders Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Esophageal Disorders Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Esophageal Disorders Treatment Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Esophageal Disorders Treatment Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Esophageal Disorders Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Esophageal Disorders Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Esophageal Disorders Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Esophageal Disorders Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Esophageal Disorders Treatment Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Esophageal Disorders Treatment Market Size by Country (2026-2031) & (US$ Million)

Table 48. Pfizer Company Details

Table 49. Pfizer Business Overview

Table 50. Pfizer Esophageal Disorders Treatment Product

Table 51. Pfizer Revenue in Esophageal Disorders Treatment Business (2020-2025) & (US$ Million)

Table 52. Pfizer Recent Development

Table 53. Bristol-Myers Squibb Company Company Details

Table 54. Bristol-Myers Squibb Company Business Overview

Table 55. Bristol-Myers Squibb Company Esophageal Disorders Treatment Product

Table 56. Bristol-Myers Squibb Company Revenue in Esophageal Disorders Treatment Business (2020-2025) & (US$ Million)

Table 57. Bristol-Myers Squibb Company Recent Development

Table 58. Perrigo Company Plc Company Details

Table 59. Perrigo Company Plc Business Overview

Table 60. Perrigo Company Plc Esophageal Disorders Treatment Product

Table 61. Perrigo Company Plc Revenue in Esophageal Disorders Treatment Business (2020-2025) & (US$ Million)

Table 62. Perrigo Company Plc Recent Development

Table 63. AstraZeneca Plc Company Details

Table 64. AstraZeneca Plc Business Overview

Table 65. AstraZeneca Plc Esophageal Disorders Treatment Product

Table 66. AstraZeneca Plc Revenue in Esophageal Disorders Treatment Business (2020-2025) & (US$ Million)

Table 67. AstraZeneca Plc Recent Development

Table 68. GlaxoSmithKline Plc Company Details

Table 69. GlaxoSmithKline Plc Business Overview

Table 70. GlaxoSmithKline Plc Esophageal Disorders Treatment Product

Table 71. GlaxoSmithKline Plc Revenue in Esophageal Disorders Treatment Business (2020-2025) & (US$ Million)

Table 72. GlaxoSmithKline Plc Recent Development

Table 73. Johnson & Johnson Company Details

Table 74. Johnson & Johnson Business Overview

Table 75. Johnson & Johnson Esophageal Disorders Treatment Product

Table 76. Johnson & Johnson Revenue in Esophageal Disorders Treatment Business (2020-2025) & (US$ Million)

Table 77. Johnson & Johnson Recent Development

Table 78. Teva Pharmaceuticals Company Details

Table 79. Teva Pharmaceuticals Business Overview

Table 80. Teva Pharmaceuticals Esophageal Disorders Treatment Product

Table 81. Teva Pharmaceuticals Revenue in Esophageal Disorders Treatment Business (2020-2025) & (US$ Million)

Table 82. Teva Pharmaceuticals Recent Development

Table 83. Medtronic Plc Company Details

Table 84. Medtronic Plc Business Overview

Table 85. Medtronic Plc Esophageal Disorders Treatment Product

Table 86. Medtronic Plc Revenue in Esophageal Disorders Treatment Business (2020-2025) & (US$ Million)

Table 87. Medtronic Plc Recent Development

Table 88. Torax Medical Company Details

Table 89. Torax Medical Business Overview

Table 90. Torax Medical Esophageal Disorders Treatment Product

Table 91. Torax Medical Revenue in Esophageal Disorders Treatment Business (2020-2025) & (US$ Million)

Table 92. Torax Medical Recent Development

Table 93. Research Programs/Design for This Report

Table 94. Key Data Information from Secondary Sources

Table 95. Key Data Information from Primary Sources

Table 96. Authors List of This Report

List of Figures

Figure 1. Esophageal Disorders Treatment Picture

Figure 2. Global Esophageal Disorders Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Esophageal Disorders Treatment Market Share by Type: 2024 VS 2031

Figure 4. Antacids Features

Figure 5. H2 Blockers Features

Figure 6. Proton Pump Inhibitors Features

Figure 7. Others Features

Figure 8. Global Esophageal Disorders Treatment Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Esophageal Disorders Treatment Market Share by Application: 2024 VS 2031

Figure 10. Hospital Pharmacies Case Studies

Figure 11. Retail Pharmacy Case Studies

Figure 12. Online Pharmacy Case Studies

Figure 13. Others Case Studies

Figure 14. Esophageal Disorders Treatment Report Years Considered

Figure 15. Global Esophageal Disorders Treatment Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Esophageal Disorders Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Esophageal Disorders Treatment Market Share by Region: 2024 VS 2031

Figure 18. Global Esophageal Disorders Treatment Market Share by Players in 2024

Figure 19. Global Top Esophageal Disorders Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Esophageal Disorders Treatment as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Esophageal Disorders Treatment Revenue in 2024

Figure 21. North America Esophageal Disorders Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Esophageal Disorders Treatment Market Share by Country (2020-2031)

Figure 23. United States Esophageal Disorders Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Esophageal Disorders Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Esophageal Disorders Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Esophageal Disorders Treatment Market Share by Country (2020-2031)

Figure 27. Germany Esophageal Disorders Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Esophageal Disorders Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Esophageal Disorders Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Esophageal Disorders Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Esophageal Disorders Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Esophageal Disorders Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Esophageal Disorders Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Esophageal Disorders Treatment Market Share by Region (2020-2031)

Figure 35. China Esophageal Disorders Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Esophageal Disorders Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Esophageal Disorders Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Esophageal Disorders Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Esophageal Disorders Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Esophageal Disorders Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Esophageal Disorders Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Esophageal Disorders Treatment Market Share by Country (2020-2031)

Figure 43. Mexico Esophageal Disorders Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Esophageal Disorders Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Esophageal Disorders Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Esophageal Disorders Treatment Market Share by Country (2020-2031)

Figure 47. Turkey Esophageal Disorders Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Esophageal Disorders Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Esophageal Disorders Treatment Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Pfizer Revenue Growth Rate in Esophageal Disorders Treatment Business (2020-2025)

Figure 51. Bristol-Myers Squibb Company Revenue Growth Rate in Esophageal Disorders Treatment Business (2020-2025)

Figure 52. Perrigo Company Plc Revenue Growth Rate in Esophageal Disorders Treatment Business (2020-2025)

Figure 53. AstraZeneca Plc Revenue Growth Rate in Esophageal Disorders Treatment Business (2020-2025)

Figure 54. GlaxoSmithKline Plc Revenue Growth Rate in Esophageal Disorders Treatment Business (2020-2025)

Figure 55. Johnson & Johnson Revenue Growth Rate in Esophageal Disorders Treatment Business (2020-2025)

Figure 56. Teva Pharmaceuticals Revenue Growth Rate in Esophageal Disorders Treatment Business (2020-2025)

Figure 57. Medtronic Plc Revenue Growth Rate in Esophageal Disorders Treatment Business (2020-2025)

Figure 58. Torax Medical Revenue Growth Rate in Esophageal Disorders Treatment Business (2020-2025)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Infectious Disease Diagnostic Testing Kit Market Research Report 2024

Gastro Esophageal Reflux Disease Drug and Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Barrett s Esophagus Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Eosinophilic Esophagitis Drug Market Research Report 2025

Global Digestive Remedies Market Research Report 2024

Anthrax Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gastrointestinal Therapeutics Market Research Report 2024

Helicobacter Pylori Infection Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Gastrointestinal Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

Global Achalasia Treatment Market Research Report 2024

Global Esophageal Cancer Drugs Market Insights Forecast to 2030

Gastroesophageal Reflux Disease GERD Treatment Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Swallowing Disorder Products Market Research Report 2024

Global Gastroesophageal Reflux Disease Treatment Device Market Insights Forecast to 2030

Global Pharyngitis Drug Market Research Report 2025

Global Esophageal Balloon Catheter Market Research Report 2024

Global Peptide Based Gastrointestinal Disorders Therapeutics Market Research Report 2024

Global Esophageal Temperature Management System Market Research Report 2025

Communicable Diseases Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-5L19798

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Chronic Pain Medical Devices Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-0I20198

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Disposable Insulin Pen Needle Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-33W11115

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Low-Density Lipoprotein Cholesterol Assay Kit Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32E19705

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions